The following excerpt tells me that they are seeing very encouraging data even though they can't release it yet.Why else would they apply for and get selected.So what if tox is great,so is that of water.They must be seeing enough to "Brag about" at ASCO otherwise why bother?

This PR tells us a lot without stepping over the line(s).

Kelt

Cellceutix was informed that the Scientific Program Committee and ASCO Leadership received more than 5,300 submissions for poster consideration at this year’s meeting.

“We are proud to have been selected to present our research on Kevetrin to the scientific community at ASCO, especially considering the large number applicants this year,” commented Dr. Krishna Menon, Chief Scientific Officer of Cellceutix. “We are particularly pleased to have been selected for presenting during the high-profile General Poster Session, which allots us additional time for our abstract and extra time for a question and answer session. We receive many inquiries about Kevetrin and its progression in clinical trials and this year’s ASCO meeting provides a fantastic platform for us to share the research with our peers.”



Read More: http://investorshangout.com/post/670303/New-E...z2P2FTs0M4